Nuclear factor erythroid-derived 2-like 2 (Nrf2) signaling abnormalities are commonly found in a variety of cancers, including HCC, and are involved in tumorigenesis, tumor progression, and chemotherapy resistance [9]. This evidence concerns the gene NFE2L2 and neoplasm.